Monomer Dynamics of Alzheimer Peptides and Kinetic Control of Early Aggregation in Alzheimer's Disease

Chemphyschem. 2016 Nov 4;17(21):3470-3479. doi: 10.1002/cphc.201600706. Epub 2016 Sep 15.

Abstract

The rate of reconfiguration-or intramolecular diffusion-of monomeric Alzheimer (Aβ) peptides is measured and, under conditions that aggregation is more likely, peptide diffusion slows down significantly, which allows bimolecular associations to be initiated. By using the method of Trp-Cys contact quenching, the rate of reconfiguration is observed to be about five times faster for Aβ40 , which aggregates slowly, than that for Aβ42 , which aggregates quickly. Furthermore, the rate of reconfiguration for Aβ42 speeds up at higher pH, which slows aggregation, and in the presence of the aggregation inhibitor curcumin. The measured reconfiguration rates are able to predict the early aggregation behavior of the Aβ peptide and provide a kinetic basis for why Aβ42 is more prone to aggregation than Aβ40 , despite a difference of only two amino acids.

Keywords: Alzheimer's disease; aggregation; inhibitors; kinetics; peptides.

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / antagonists & inhibitors
  • Amyloid beta-Peptides / chemistry*
  • Amyloid beta-Peptides / metabolism*
  • Curcumin / pharmacology
  • Humans
  • Kinetics
  • Protein Aggregates / drug effects
  • Thermodynamics*

Substances

  • Amyloid beta-Peptides
  • Protein Aggregates
  • Curcumin